How to Read a Peptide Certificate of Analysis

A peptide Certificate of Analysis (COA) is a batch-specific laboratory report that documents the identity, purity, and safety characteristics of a peptide production lot. A useful COA names the peptide, links to a specific batch or lot number, and reports the analytical results — typically HPLC purity, mass-spectrometric identity, appearance, and endotoxin — using named methods with defined thresholds. Reading it correctly is how a researcher decides whether a vial is fit for the experiment on the bench.

Updated August 28, 2026 · Peptide Research Guides · ~10 min read

What Is a Peptide Certificate of Analysis?

A Certificate of Analysis is the analytical fingerprint of a specific production batch. It is generated after the peptide has been synthesized, purified, freeze-dried, and vialled, and it is intended to travel with that batch through storage, shipping, and end use. It is not a marketing document and it is not a summary of the vendor’s process — it is a set of measurements taken on the material in the vial you are holding.

Every AppealLabs batch is third-party tested and every result is published on the site before purchase — no account, no email, no waiting until after checkout.

Why Peptide COAs Matter in Laboratory Research

A COA matters because peptide synthesis is not error-free. Deletion sequences, truncated products, oxidation of methionine and cysteine, deamidation of asparagine and glutamine, and residual synthesis reagents such as trifluoroacetic acid all show up in real production runs. A batch stamped “99% pure” that lacks a supporting chromatogram, a molecular-weight measurement, and a batch identifier is a claim, not a result. Without a COA, a researcher has no way to reconcile experimental variability with actual material quality — and no way to reproduce a result across batches.

Anatomy of a Peptide COA — Every Section Explained

Peptide COAs are not standardized across the industry, but a legitimate one contains the same core sections. The following breakdown covers each in the order you will typically encounter it on the document.

1. Header and Product Identification

The top of the COA names the peptide, the manufacturer, and, when applicable, the independent analytical laboratory that generated the results. Look for the peptide’s common name (for example, BPC-157 or Tesamorelin), the CAS number if one exists, and the vialled mass or volume the report applies to. A COA that identifies the peptide only by an internal SKU with no chemical name is a weak COA.

2. Batch or Lot Number, Manufacturing Date, and Report Date

A COA is bound to a batch, not to a product family. The batch or lot number should match the number printed on the vial and on the outer packaging. A manufacturing date establishes shelf-life context, and a report date shows when the analytical work was actually performed. A COA that reports today’s date on a five-year-old batch is essentially a re-print.

3. Peptide Sequence, Molecular Formula, and Molecular Weight

The document should print the one-letter or three-letter amino-acid sequence, the molecular formula, and the theoretical monoisotopic and average molecular weights. These are the reference values against which the mass-spectrometry section is judged. If the theoretical molecular weight is missing, the mass-spec result cannot be interpreted.

4. Appearance

Most freeze-dried research peptides are reported as “white to off-white lyophilized powder” or “white lyophilized cake”. Yellowing, browning, or visible particulate is a red flag for oxidation or contamination. Appearance is the cheapest quality check on the entire document.

5. HPLC Purity

High-Performance Liquid Chromatography (HPLC), typically reversed-phase (RP-HPLC), separates the target peptide from truncation products, deletion sequences, and reagent residues. The main peak is integrated and reported as a percentage of the total peak area, using a defined wavelength (commonly 214 nm for the peptide backbone, or 220 nm). A full COA also includes the chromatogram itself so that the shape of the main peak, the presence of shoulder peaks, and the baseline can be judged directly. A “purity ≥ 99%” line without a chromatogram is an assertion, not evidence.

6. Mass Spectrometry (Identity)

Electrospray Ionization (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry confirms the peptide’s identity by measuring its molecular weight. The observed monoisotopic or average mass should match the theoretical value from the sequence within the method’s tolerance. Large deviations indicate either a wrong peptide or a chemical modification such as oxidation (+16 Da per oxygen), phosphorylation (+80 Da), or unremoved protecting groups.

7. Water Content

Residual water in a lyophilized peptide affects both mass and stability. It is typically measured by Karl Fischer titration and reported as a percentage. A dry, well-lyophilized peptide is usually below a few percent water. High water content shortens shelf life and shifts the effective peptide mass in a vial.

8. Counterion Content (TFA / Acetate)

Solid-phase peptide synthesis leaves residual counterions, most often trifluoroacetate (TFA) from purification. The COA should report the counterion identity and its percentage. TFA content matters because the mass on the label includes the salt: a “5 mg” TFA-salt vial contains less net peptide than a 5 mg acetate-salt vial. For sensitive experiments, acetate-exchanged material is preferred.

9. Endotoxin / Bioburden

Endotoxins are lipopolysaccharide fragments from Gram-negative bacteria that can confound biological assays even at very low concentrations. The Limulus Amebocyte Lysate (LAL) assay is the standard method and results are reported in endotoxin units per milligram (EU/mg). USP General Chapter <85> describes the accepted methodology. Peptides destined for cell-based work should be low-endotoxin.

HPLC vs. Mass Spectrometry — What Each One Actually Verifies

HPLC and mass spectrometry are complementary, not redundant. A COA that reports only one of them is incomplete.

Method	Answers the question	What it does not tell you
RP-HPLC	How pure is the material relative to related impurities?	Whether the main peak is actually the correct peptide
ESI-MS or MALDI-TOF	What is the molecular mass of the main species — is this the right peptide?	Whether there are related impurities beside the target
Combined	The vial contains the correct peptide at the reported purity	—

What Does “99% Purity” Actually Mean on a Peptide COA?

“99% purity” on a peptide COA means that the main HPLC peak accounts for 99% of the total integrated peak area at a defined detection wavelength, and that all other detected species combined account for the remaining 1%. It does not by itself confirm identity — a COA needs to pair the purity figure with a mass-spectrometry result showing that the main peak matches the theoretical molecular weight of the intended peptide.

Two subtleties matter. First, HPLC purity is method-dependent: gradient, column, and detector wavelength all shift the number. Second, the reported percentage is a peak-area percentage, not a mass percentage of net peptide, which is why the counterion and water sections of the COA remain relevant.

How to Spot a Fake or Misleading Peptide COA

No batch or lot number, or a batch number that does not match the vial
Purity claimed without an attached HPLC chromatogram
Mass-spectrometry result missing, or theoretical molecular weight omitted
A generic PDF reused across every product on the site
Signature or lab name absent, unreadable, or clearly stock imagery
Perfectly round purity figures (“99.9%”) with no supporting data table
Report date that predates the manufacturing date
An “internal” report from the seller with no reference to independent analysis
No wavelength or method described alongside the HPLC number
Endotoxin section missing on a peptide intended for cell-based work

What Independent Third-Party Testing Adds

An independent laboratory result is not automatically better than an in-house result — but it is harder to manipulate. Third-party testing separates the analyst from the commercial interest, publishes results against externally documented methods, and produces a record the customer can cross-reference. When a supplier publishes third-party COAs openly, and each batch’s report is linked to the batch it describes, the entire chain from synthesis to shelf is verifiable.

How to Cross-Check a COA Before Running an Experiment

Confirm the batch number on the COA matches the number on the vial and outer box.
Confirm the peptide name and sequence on the COA match the product you ordered.
Compare the reported molecular weight to the theoretical molecular weight — they should agree within the method’s tolerance.
Check the HPLC method line: column, gradient, and detection wavelength should all be named.
Inspect the chromatogram: a clean, symmetric main peak with a flat baseline; watch for shoulders.
Verify the appearance description matches what is actually in the vial.
Confirm the report date is recent enough to reflect the current lot rather than a legacy retest.
For cell-based work, verify an endotoxin result is present and within your assay’s tolerance.

Key Takeaways

A peptide COA is a batch-specific analytical report — not a marketing summary.
HPLC verifies purity; mass spectrometry verifies identity. A trustworthy COA carries both.
Purity is a peak-area percentage at a defined wavelength — not a net-peptide mass percentage.
Counterion content, water content, and endotoxin data change the effective quality of the vial.
Batch and lot numbers must reconcile the COA to the physical vial in front of you.
Independent third-party testing is more credible than in-house-only assertions.

Frequently Asked Questions

What purity level should a research peptide COA show?

Most research-grade peptides target ≥95% HPLC purity, with 98–99% common for high-quality suppliers. The right target depends on the assay: sensitive receptor-binding or cell-based work usually requires 98% or higher, while some biochemical screens tolerate lower purity if impurities are characterized.

Is a supplier-issued COA trustworthy?

A supplier-issued COA is only as trustworthy as its methods and its willingness to be verified. Legitimate suppliers name the analytical methods, publish the chromatograms, disclose the testing laboratory, and pair the report with an independent third-party analysis. AppealLabs publishes its third-party COAs openly at appeallabs.com/lab-results before purchase.

What does it mean if the observed mass differs from the theoretical mass?

Small deviations within the instrument’s ppm tolerance are normal. Larger discrepancies indicate either the wrong peptide, an incomplete deprotection, oxidation (a +16 Da shift per added oxygen), or a chemical modification. Any mass difference outside the stated tolerance should be treated as a fail.

How long is a peptide COA valid?

A COA reports the batch as it existed at the time of testing. It does not expire, but it also does not guarantee stability beyond that point. Storage conditions, exposure to moisture, and freeze–thaw cycles all shift the material over time and can invalidate the original results.

Should endotoxin always be on a peptide COA?

Endotoxin is essential for peptides going into cell-based or in-vivo research and less critical for purely chemical or analytical work. If the COA does not report an endotoxin result and the intended application involves living cells or tissues, request the data before proceeding.

What is TFA content and why does it matter?

Trifluoroacetic acid (TFA) is a common counterion left over from peptide purification. Because the labelled mass on the vial includes the counterion, a peptide reported as “5 mg” TFA-salt contains less net peptide than 5 mg of acetate-salt or free-base material. TFA can also interfere with sensitive cellular assays, which is why acetate-exchanged peptides are preferred in some workflows.

What if a supplier will not provide a COA?

Treat the vial as unknown material. A supplier that cannot or will not supply a batch-specific COA has no evidence to offer for identity or purity, and any experimental result generated from that vial is uninterpretable.

References

U.S. Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. usp.org
U.S. Food & Drug Administration & ICH. Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. fda.gov
National Institute of Standards and Technology. Peptide Standards program. nist.gov
Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. Indexed at PubMed.
Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. Indexed at PubMed.

Research-use disclaimer. All peptides sold by AppealLabs are labelled FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION. Content on this page describes analytical documentation only and is not medical advice. Nothing here should be interpreted as diagnosing, treating, curing, or preventing any disease, or as guidance for human use of any peptide.